RESUMO
OBJECTIVES: The quality of amoxicillin capsules, ceftriaxone for injection, and ciprofloxacin tablets was evaluated to determine whether there is any difference in quality when comparing the country of origin. This was undertaken because it has been claimed that antibiotics manufactured in Europe are of superior quality to those originating from Africa or Asia. METHODS: Samples of amoxicillin capsules, ceftriaxone for injection, and ciprofloxacin tablets were collected from three randomly selected wholesale pharmacies in each city, namely Arusha, Dar es Salaam and Mwanza, Tanzania. The collected samples of collected brands were subjected to quality control testing as per their respective pharmacopoeial monographs. Amoxil 250â mg capsules (Glaxo Wellcome, Mayenne, France), Rocephin (Roche, Switzerland) and Cipro-Denk 500 (Allphamed Pharbil Arzneimittel GmbH, Gottingen, Germany) were used as reference brands for the other generic brands of amoxicillin, ceftriaxone and ciprofloxacin, respectively. RESULTS: A total of 31 brands (10 different brands of amoxicillin capsules, 9 of ceftriaxone sodium injections, and 12 of ciprofloxacin tablets) were collected from the targeted regions and subjected to quality control testing. All samples of collected brands complied with the requirements of their respective pharmacopoeial monographs. CONCLUSIONS: There was no significant difference in quality between brands of amoxicillin capsules, ceftriaxone for injection, and ciprofloxacin tablets manufactured in Africa and Asia against those manufactured in Europe in terms of compliance with the respective pharmacopoeial monographs.
Assuntos
Antibacterianos , Ciprofloxacina , Controle de Qualidade , Tanzânia , Antibacterianos/análise , Ciprofloxacina/análise , Humanos , Ceftriaxona/análise , Ceftriaxona/química , Amoxicilina/análise , Amoxicilina/normas , Amoxicilina/química , ComprimidosRESUMO
A dual-emission ratiometric fluorescence sensor (CDs@CdTe@MIP) with a self-calibration function was successfully constructed for AMO detection. In the CDs@CdTe@MIP system, non-imprinted polymer-coated CDs and molecule-imprinted polymer-coated CdTe quantum dots were used as the reference signal and response elements, respectively. The added AMO quenched the fluorescence of the CdTe quantum dots, whereas the fluorescence intensity of the CDs remained almost unchanged. The AMO concentration was monitored using the fluorescence intensity ratio (log(I647/I465)0/(I647/I465)) to reduce interference from the testing environment. The sensor with a low detection limit of 0.15 µg/L enabled detection of the AMO concentration within 6 min. The ratiometric fluorescence sensor was used to detect AMO in spiked pork samples; it exhibited a high recovery efficiency and relative standard deviation (RSD) of 97.94-103.70% and 3.77-4.37%, respectively. The proposed highly sensitive and selective platform opens avenues for sensitive, reliable, and rapid determination of pharmaceuticals in the environment and food safety monitoring using ratiometric sensors.
Assuntos
Amoxicilina , Compostos de Cádmio , Limite de Detecção , Impressão Molecular , Pontos Quânticos , Espectrometria de Fluorescência , Telúrio , Pontos Quânticos/química , Compostos de Cádmio/química , Telúrio/química , Espectrometria de Fluorescência/métodos , Amoxicilina/análise , Amoxicilina/química , Corantes Fluorescentes/química , Sulfetos/química , Animais , Contaminação de Alimentos/análise , Polímeros Molecularmente Impressos/química , SuínosRESUMO
Dual-emissive fluorescence probes were designed by integrating porphyrin into the frameworks of UiO-66 for ratiometric fluorescence sensing of amoxicillin (AMX). Porphyrin integrated UiO-66 showed dual emission in the blue and red region. AMX resulted in the quenching of blue fluorescence component, attributable to the charge neutralization and hydrogen bonds induced energy transfer. AMX was detected using (F438/F654) as output signals. Two linear relationships were observed (from 10 to 1000 nM and 1 to 100 µM), with a limit of detection of 27 nM. The porphyrin integrated UiO-66 probe was used to detect AMX in practical samples. This work widens the road for the development of dual/multiple emissive fluorescence sensors for analytical applications, providing materials and theoretical supporting for food, environmental, and human safety.
Assuntos
Amoxicilina , Antibacterianos , Corantes Fluorescentes , Leite , Porfirinas , Espectrometria de Fluorescência , Leite/química , Porfirinas/química , Antibacterianos/análise , Antibacterianos/química , Amoxicilina/análise , Amoxicilina/química , Corantes Fluorescentes/química , Animais , Espectrometria de Fluorescência/métodos , Limite de Detecção , Estruturas Metalorgânicas/química , Resíduos de Drogas/análise , Contaminação de Alimentos/análiseRESUMO
Amoxicillin, a member of the penicillin family, is primarily utilized for the treatment of various bacterial infections affecting ears, nose, throat, urinary tract, and skin. Given its widespread application in medicine, agriculture, environment, and food industry, the precise and sensitive detection of amoxicillin is important. This study introduces a novel approach to developing a sensitive and selective fluorescent aptasensor relying on fluorescence resonance energy transfer (FRET) for the specific detection of amoxicillin. The carboxyfluorescein-labeled aptamer serves as a energy donor, while MXene functions as an energy acceptor, and acting as a quencher. To achieve optimal detection efficiency, a dual optimization strategy utilizing RSM-CCD and ANN-GA was used to fine-tune experimental conditions. The fluorescence measurements revealed an expansive linear range extending from 100 to 2400 ng mL-1, accompanied by an exceptionally low detection limit of 1.53 ng mL-1. Additionally, it shows an excellent selectivity towards amoxicillin over other antibiotics commonly found in water matrices. The aptasensor demonstrates good stability and reproducibility; effectiveness of the aptasensor was validated by testing in real water samples. This remarkable sensitivity and broad dynamic range affirm the efficacy aptasensor in accurately detecting varying concentrations of amoxicillin in wastewater bodies.
Assuntos
Amoxicilina , Técnicas Biossensoriais , Amoxicilina/análise , Amoxicilina/química , Transferência Ressonante de Energia de Fluorescência/métodos , Aptâmeros de Nucleotídeos/química , Fluorescência , Poluentes Químicos da Água/análise , Água/químicaRESUMO
Solar Fenton is an important and extensively used advanced oxidation process (AOP) to degrade pharmaceutical pollutants. The objective of this study was to evaluate the performance of simultaneous degradation of the mixed pollutants (amoxicillin, acetaminophen, and ciprofloxacin) for an aqueous solution using the solar Fenton process. Operating parameters such as pH, iron doses, H2O2 doses, pollutant concentrations, and time were studied. From the experimental results, the ideal conditions were obtained for the removal of mixed pollutants such as pH 3, Fe2+ 0.04 mM, H2O2 4 mM, the concentration of the mixed pollutants 5 mg/L, solar radiation 400 W/m2, and time 10 min, respectively. The pseudo-first-order kinetics were utilized to investigate the degradation efficacy of the mixed pollutants. The result of the study indicates that the degradation efficiency was > 99% for the mixed pollutants. A maximum of 63% mineralization was observed, and hydroxyl radical scavenger effects were studied. The best optimal conditions were applied to assess the spiked wastewater (municipal wastewater (MWW) and hospital wastewater (HWW)). The highest elimination rates for AMX, ACET, and CIP were observed as 65%, 89%, and 85% for MWW and 76%, 92%, and 80% for HWW, respectively. The degraded by-products were detected by LC-ESI-MS in the water matrix (aqueous solution and spiked wastewater), and ECOSAR analysis was performed for the transformed products. The study concluded that the solar Fenton technique is promising and effective for the removal of mixed pollutants from the water matrix.
Assuntos
Peróxido de Hidrogênio , Ferro , Luz Solar , Eliminação de Resíduos Líquidos , Poluentes Químicos da Água , Poluentes Químicos da Água/análise , Poluentes Químicos da Água/química , Peróxido de Hidrogênio/química , Cinética , Ferro/química , Eliminação de Resíduos Líquidos/métodos , Águas Residuárias/química , Oxirredução , Ciprofloxacina/química , Ciprofloxacina/análise , Acetaminofen/química , Acetaminofen/análise , Amoxicilina/química , Amoxicilina/análiseRESUMO
To date, there is an increased risk to public health and the environment due to the presence of pharmaceutically active compounds within drinking water supply and distribution networks. Owing to this, a direct injection-HPLC/MS-MS method was developed for the simultaneous determination of 16 active pharmaceutical compounds in tap water samples: amoxicillin, ampicillin, cephalexin, cefotaxime, cefuroxime, ciprofloxacin, clarithromycin, clindamycin, chloramphenicol, cyproterone, erythromycin, flutamide, spironolactone, sulfamethoxazole, tamoxifen, and trimethoprim. Limits of detection (LOD) ranged from 0.2 to 6.0 µg/L while quantification limits (LOQ) from 0.3 to 20 µg/L. Recovery percentages were between 70 and 125%. Total analysis time was short, with all compounds being resolved in less than 2.1 min. Of the 22 tap water samples collected and analyzed, the highest concentrations corresponded to amoxicillin (147 µg/L) and ciprofloxacin (44 µg/L). The findings could set a precedent for establishing safe levels of these compounds and increasing standards for tap water quality in this region.
Assuntos
Água Potável , Monitoramento Ambiental , Espectrometria de Massas em Tandem , Poluentes Químicos da Água , Poluentes Químicos da Água/análise , Cromatografia Líquida de Alta Pressão , Água Potável/química , Monitoramento Ambiental/métodos , Preparações Farmacêuticas/análise , Limite de Detecção , Ciprofloxacina/análise , Abastecimento de Água , Amoxicilina/análiseRESUMO
THE AIM OF THE STUDY: Was to determine the presence of an amoxicillin-based antibiotic in bone implant biopsies by Raman spectroscopy in an experiment. MATERIALS AND METHODS: Experimental animals (n=10, a miniature pig of the Svetlogorsk breed) were divided into 2 groups of 5 animals. Groups 1 and 2 were injected with amoxicillin 2 ml per 20 kg of body weight 30 minutes before dental implantation surgery, then group 2 was additionally injected with 1 ml per 20 kg of body weight for 5 days. Each animal has 6 implants installed. On the 1st, 3rd, 7th, 14th day, an implant-bone biopsy was removed from each animal, micro-preparations were made and Raman spectroscopy was performed to assess the peak matching of the Raman spectrum. RESULTS: In animals of the 1st and 2nd groups, the main peak of the Raman spectrum, which is closest to the values of the antibiotic spectrum of interest to us, is located closer to 1448 cm-1 and 1446 cm-1, respectively. At the same time, in both observations, the peaks relate to the spectrum of bone tissue, which cannot indicate the content of an antibiotic in the drug. CONCLUSION: No scattering spectra corresponding to the antibiotic molecule were found in any animal from both groups, regardless of the mode of administration and dosage of amoxicillin. The detected peaks corresponded to bone tissue without an antibiotic.
Assuntos
Amoxicilina , Antibacterianos , Implantes Dentários , Análise Espectral Raman , Análise Espectral Raman/métodos , Animais , Amoxicilina/análise , Amoxicilina/administração & dosagem , Suínos , Antibacterianos/análise , Antibacterianos/administração & dosagem , Biópsia , Porco Miniatura , Osso e Ossos/química , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/patologia , Implantação Dentária/métodosRESUMO
In this study, a cheap, fast and simple orbital shaker-assisted fatty acid-based switchable solvent microextraction (OS-FASS-ME) procedure was developed for the extraction of amoxicillin (AMOX) in dairy products, pharmaceutical samples and wastewater prior to its spectrophotometric analysis. Fatty acid-based switchable solvents were investigated for extracting AMOX. The key factors of the OS-FASS-ME procedure were optimized using a central composite design. The linearity of OS-FASS-ME procedure was in the range 5-600 ng mL-1 with a correlation coefficient of 0.991. In five replicate experiments for 20 ng mL-1 of AMOX solution, the recovery and relative standard deviation were 95.8% and 2.2%, respectively. Limits of detection and quantification were found 1.5 ng mL-1 and 5 ng mL-1, respectively. The accuracy, precision, robustness and selectivity of the OS-FASS-ME procedure were investigated in detail under optimum conditions. The OS-FASS-ME procedure was applied to milk, cheese, wastewater, syrups and tablets. A comparison of the results obtained from the reference method and the OS-FASS-ME method showed that the OS-FASS-ME procedure can be successfully applied to complex matrices.
Assuntos
Amoxicilina , Ácidos Graxos , Microextração em Fase Líquida , Amoxicilina/química , Amoxicilina/isolamento & purificação , Amoxicilina/análise , Microextração em Fase Líquida/métodos , Ácidos Graxos/química , Águas Residuárias/química , Águas Residuárias/análise , Antibacterianos/química , Antibacterianos/análise , Antibacterianos/isolamento & purificação , Solventes/química , Química Verde , Animais , Leite/química , Laticínios/análiseRESUMO
Pharmaceutical pollution has received considerable attention because of the harmful effects of pharmaceutical compounds on human health, even in trace amounts. Amoxicillin is one of the frequently used antibiotics that was included in the list of emerging water pollutants. Therefore, a highly selective and rapid technique for amoxicillin detection is required. In this work, a new aptamer was selected for amoxicillin and utilized for the development of a label-free electrochemical aptasensor. Aptamer selection was performed using the systematic evolution of ligands by exponential enrichment. The selected aptamer showed good specificity against other antibiotics, including the structurally related antibiotics: ampicillin and ciprofloxacin. Among the selected aptamers, Amx3 exhibited the lowest dissociation constant value of 112.9 nM. An aptasensor was developed by immobilization of thiolated Amx3 aptamer onto gold screen-printed electrodes via self-assembly, which was characterized using cyclic voltammetry and electrochemical impedance spectroscopy. The detection was realized by monitoring the change in the differential pulse voltammetry peak current in the ferro/ferricyanide redox couple upon binding of the aptasensor to amoxicillin. The aptasensor showed very good sensitivity with an ultralow limit of detection of 0.097 nM. When the aptasensor was tested using actual spiked milk samples, excellent recovery percentages were observed. The label-free electrochemical aptasensor developed herein is a promising tool for the selective and sensitive detection of amoxicillin in environmental samples.
Assuntos
Amoxicilina , Aptâmeros de Nucleotídeos , Técnicas Biossensoriais , Técnicas Eletroquímicas , Leite , Amoxicilina/análise , Amoxicilina/química , Aptâmeros de Nucleotídeos/química , Técnicas Biossensoriais/métodos , Técnicas Eletroquímicas/métodos , Leite/química , Antibacterianos/análise , Antibacterianos/química , Eletrodos , Ouro/química , Animais , Limite de Detecção , Técnica de Seleção de AptâmerosRESUMO
O objetivo foi avaliar a eficácia da amoxicilina em diferentes periodos (3 e 7 dias) no tratamento coadjuvante de abscessos dentoalveolares após realização de drenagem. Foram avaliados 20 voluntários divididos em 2 grupos (n=10): G1 - 19 de amoxicilina, antes do procedimento de drenagem e 500mg de 8/8h por 3 dias; G2 - 1 9 de amoxicilina antes do procedimento e 500mg de 8/8h por 7 dias. Foram avaliados o edema, dor, febre, supuração e trismo, e os voluntários tiveram acompanhamento clínico diário. O edema foi avaliado em duas medidas (Tragus a Asa do Nariz e Tragus a Comissura Labial). A abertura bucal e o edema foram avaliados antes da drenagem, 1, 2, 3 e 7 dias após. Para a avaliação de dor foi utilizada a escala analógica visual (EAV) antes e nos intervalos O, 1 h, 2h, 4h, 12h, 1 dia, 2 dias, 3 dias e 1 semana após. Os resultados fora m su bmetidos à a ná I ise estatística (Kruska II-Wa II is), com n ivel de sig n ificâ ncia de 5%. Quanto aos parâmetros clínicos avaliados, não foram observadas diferenças estatisticamente significantes entre os grupos [p>0,05), e nenhum dos voluntários apresentou complicações no período do pós-atendimento. Concluiu-se que, após a intervenção clínica, a eficácia da amoxicilina nos períodos avaliados foi similar na amostra avaliada
The aim of this study was to compare the use of amoxicillin for different time intervals (3 and 7 days) for treatment of acute dentoalveolar abscesses after performing drainage. Twenty volunteers were divided into two groups (n = 10): G 1 - The volunteers received 1 9 of amoxicillin before the drainage procedure, and 500mg of amoxicillin every 8 hours for 3 days; G2 - The volunteers received 19 of amoxicillin before the drainage procedure, and 500mg of amoxicillin every 8 hours for 7 days. For each patient followed-up, acute infectious conditions were investigated, and pain, edema, fever, suppuration and trismus were evaluated. To evaluate pain was used a visual analog scale [VAS) in the intervals O, 1 h, 2h , 4h , 12 h , 1,2 and 3 days and 1 week after the drainage. The results were submmited to statistical analysis [Kruskal - Wallisl. with a significance levei of 5 %. There was no statistically significant difference between the groups considering the parameters evaluated [p>0.05). None of the volunteers had complications in the post clinical care assessed. It was concluded that after clinical intervention, the effectiveness of the use of amoxicillin in periods of 3 and 7 days was similar in the evaluated volunteers
Assuntos
Humanos , Masculino , Feminino , Abscesso/terapia , Amoxicilina/análise , Antibacterianos/uso terapêuticoRESUMO
The amount of amoxicillin in pharmaceutical formulations was determined using spectra of diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), in association with partial least squares (PLS) regression. The spectra of 24 different samples (17 for the calibration set and 7 for the validation set), which had been registered using a Nicolet Magna 550 spectrophotometer, contained 76.7-94.3 percent of amoxicillin in starch. The PLS models were constructed with auto-scaled or variance-scaled data, and multiplicative scatter correction (MSC). The best model presented R²=0.9936, RMSEC=0.441 and RMSEV=0.790. The analytical method proposed is non-destructive and the cost and time of analysis are very much reduced, allowing for the fast and direct determination of amoxicillin content.
Neste trabalho propõe-se a quantificação de amoxicilina em formulações farmacêuticas empregando espectroscopia por refletância difusa no infravermelho com transformada de Fourier (DRIFTS) e regressão por mínimos quadrados parciais (PLS). Foram coletados em um espectrômetro Nicolet Magna 550 os espectros de 24 amostras (17 para o conjunto de calibração e 7 para o conjunto de validação) contendo de 76,7-94,3 por cento de amoxicilina em amido. Para a construção dos modelos PLS foi empregada a correção do espalhamento de luz (MSC) e os dados foram autoescalados ou escalados pela variância. Foi obtido um excelente modelo para a previsão da amoxicilina o qual apresentou R²=0,9936, RMSEC=0,441 e RMSEV=0,790. O método proposto além de não destrutivo apresenta baixo tempo de análise e baixo custo podendo ser facilmente empregado no controle de qualidade das indústrias farmacêuticas.
Assuntos
Amoxicilina/análise , Preparações Farmacêuticas , Espectroscopia de Infravermelho com Transformada de Fourier/métodos , Controle de QualidadeRESUMO
El objetivo del presente trabajo fue conocer la sensibilidad antibiótica de Streptococcus pneumoniae a los antimicrobianos usados con más frecuencia en la práctica clínica y revisar las recomendaciones actuales de tratamiento de la enfermedad neumocócica. Durante el periodo octubre 2000 a septiembre 2002 se recogieron los datos demográficos, el diagnóstico clínico del paciente, el origen de la muestra y la sensibilidad antibiótica de todos los Streptococcus pneumoniae aislados en los laboratorios de microbiología del Servicio Navarro de Salud, que atienden a una población de 555.829 habitantes. Se obtuvieron 465 aislamientos de Streptococcus pneumoniae (166 de origen invasor). Los aislamientos procedentes de exudado ótico fueron los más resistentes y los de hemocultivo los más sensibles. El porcentaje de resistencia a penicilina fue del 43 por ciento, 6,1 por ciento para amoxicilina y 6,6 por ciento para cefotaxima. El 36,3 por ciento de los aislamientos fueron resistentes a eritromicina, de ellos un 85,45 por ciento exhibía un fenotipo MLSB y un 14,55 por ciento un fenotipo M. Se detectó multirresistencia en un 32,3 por ciento de los aislamientos. La resistencia de Streptococcus pneumoniae a betalactámicos, especialmente penicilina, amoxicilina y cefotaxima/ceftriaxona no impide su uso clínico en la mayoría de los aislamientos de Streptococcus pneumoniae de nuestra área, exceptuando los casos de meningitis neumocócica (AU)
Assuntos
Adolescente , Adulto , Idoso , Feminino , Masculino , Pessoa de Meia-Idade , Criança , Humanos , Sensibilidade e Especificidade , Streptococcus pneumoniae/isolamento & purificação , Streptococcus pneumoniae/patogenicidade , Resistência Microbiana a Medicamentos/fisiologia , Resistência às Penicilinas , Amoxicilina/análise , Amoxicilina/isolamento & purificação , Cefotaxima/isolamento & purificação , Cefotaxima/análise , Lactamas/isolamento & purificação , Lactamas/análise , Eritromicina/isolamento & purificação , Eritromicina/análise , Prognóstico , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Análise Custo-Benefício/normasRESUMO
Background: Delayed reactions with betalactam antibiotics are a very common reason for consultationand a matter of numerous publications. Objective: To demonstrate that delayed reactions occurring during treatment with betalactam antibiotics are not reproduced in a high percentage of the patients, when making drug challenge.To analyse the characteristics of people showing this type of reaction. Methods: We included in our study all the patients who came to our Allergy Department during one year (2004), with a clinical history of delayed reaction (> 72h) to betalactams. Skin prick tests (SPT), intradermal tests (IT) and patch tests were carried out, followed by simple blind placebo controlled drug challenge (SBPCDC) at hospital and home treatment with betalactams. Results: We studied 23 patients (12 men and 11 women), average age 23.4 years old. SPT and patch test were negative in all patients. Only one patient showed positive IT tests, and allergic reaction was only reproduced in two patients; 76 % tolerated the drug involved in supposed allergy. Conclusions: Simple blind oral challenge with implicated drug followed by home treatment is required for a conclusive diagnosis of allergy in patients with delayed reactions to betalactams
No disponible